Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
-
Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results
-
Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Model N Announces Date of Second Quarter Fiscal Year 2024 Financial Results
-
NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
-
Airship AI to Ring the Nasdaq Closing Bell on Wednesday, May 15, 2024
-
Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
Arteris Announces Financial Results for the First Quarter 2024 and Second Quarter and Full Year 2024 Guidance
-
Udemy Reports First Quarter 2024 Results
-
Twelve Seas Investment Company II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
-
Jaguar Growth Partners Enters U.S. Market With $24 Million Acquisition of Multi Property Residential Platform in New York City
-
Altair Announces First Quarter 2024 Financial Results
-
Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights
-
iRhythm Technologies Announces First Quarter 2024 Financial Results
-
Paylocity Announces Third Quarter Fiscal Year 2024 Financial Results
-
SIMPPLE LTD. Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
-
Fidus Investment Corporation Announces First Quarter 2024 Financial Results
-
Nasdaq April 2024 Volumes
-
Pactiv Evergreen Inc. Declares Quarterly Dividend
-
Pactiv Evergreen Reports First Quarter 2024 Financial Results
-
OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
-
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applications
-
89bio to Host Key Opinion Leader Webinar on Pegozafermin’s Opportunity in Advanced MASH
-
Sprout Social Announces First Quarter 2024 Financial Results
-
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
AvePoint to Participate in Upcoming Investor Conferences
-
Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
-
Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024
-
Trupanion’s Margi Tooth Appointed Chief Executive Officer Effective August 1, 2024
-
Monster Beverage Reports 2024 First Quarter Results
-
Texas Roadhouse, Inc. Announces First Quarter 2024 Results
-
EMCORE Corporation to Host Fiscal 2024 Second Quarter Conference Call on May 8, 2024
-
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
-
BJ’s Restaurants, Inc. Reports Fiscal First Quarter 2024 Results
-
Corvus Pharmaceuticals to Provide Business Update and First Quarter 2024 Financial Results on May 6, 2024
-
CSX Executive Vice President and Chief Commercial Officer to Address Bank of America Transportation, Airlines and Industrials Conference
-
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
-
Mustang Bio Announces Closing of $4 Million Public Offering
-
Asure Announces First Quarter 2024 Results
-
EMCORE Announces Sale of Chips Business and Wafer Fabrication Operations for $2.92M and Certain Assumed Liabilities
-
Ascendis Pharma Reports First Quarter 2024 Financial Results
-
Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer
-
Silvercrest Asset Management Group Inc. Reports Q1 2024 Results
-
Willscot Mobile Mini Reports First Quarter 2024 Results
-
Alignment Healthcare Reports First Quarter 2024 Results
-
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
-
WW International, Inc. Announces First Quarter 2024 Results
-
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
-
Aspen Group, Inc. Amends Debentures
-
Gevo Reports First Quarter 2024 Financial Results
